Virginia woolf and E.M. Forster from a psychoanalytic perspective in the modern age
Is this your thesis?
This record came from a bulk archive import. If it’s yours, link it to your profile.
Abstract (EN)
Edward Morgan Forster and Virginia Woolf who were modernist novelists that lived and wrote during early 20th cc. They lived in such an age that women, homosexuals and bisexuals didn't have full freedom of self-revelation even to write and express themselves. There was no outlet for them to express their thoughts and emotions. At this point, their novels A Passage to India and Orlando respectively represent a canon of the age of modernism. Regardless of the time, the characters in question achieve catharsis finding an outlet for the writers' wishes under psychoanalytic theories of uncanny, dream and wish-fulfillment. Thereby, they regulate their psychological state with the help of both conscious and unconscious fantasies and aims. Regardless of the personality and gender of the author; the characters find their way to relieve the cathexis embedded in authors' mind via uncanny, dream and wish-fulfillment theories.
Author
Elçin Özkarakaş
Institution
How to Cite
Elçin Özkarakaş (Master Thesis). Virginia woolf and E.M. Forster from a psychoanalytic perspective in the modern age, 2017, Yeditepe University.
Keywords
License
Tüm Hakları Saklıdır
This work is shared under the specified license terms.
More theses from Yeditepe University
- Studies on cyclodextrin complexation of a poorly water soluble anti-hyperlipidemic drug, tablet formulation and characterization(2021)
- Washington ambassadors in Turkish-US relations (1927-1960)(2023)
- Metamorphosis of female voices: A study of the violation of women in Greek and Roman mythology and feminist rewritings reclaiming the narrative(2022)
- Knowledge distillation with foundation models for image segmentation(2023)
- The relationship between machiavelism, grandiose and vulnerable narcissism, and loneliness among white collar workers(2023)
- Evaluation of drug-drug interaction checkers along clinically relevant adverse drug events in oncology and hematology pediatric patients(2023)